Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,346
Closed -$61K 586
2017
Q2
$61K Buy
+1,346
New +$59.4K 0.04% 447
2017
Q1
Sell
-11,809
Closed -$474K 750
2016
Q4
$474K Buy
+11,809
New +$456K 0.32% 93
2016
Q3
Sell
-3,791
Closed -$131K 716
2016
Q2
$131K Buy
3,791
+3,231
+577% +$112K 0.14% 252
2016
Q1
$19K Sell
560
-882
-61% -$30.8K 0.02% 424
2015
Q4
$56K Buy
+1,442
New +$56.1K 0.05% 350

Other funds holding HOLX

Invictus RG's HOLX Position: Q3 2017 in Review

Invictus RG sold out of Hologic (HOLX) in Q3 2017, closing a stake of 1,346 shares — an estimated $61K sold.

Invictus RG first reported a position in HOLX in Q4 2015 and held it in 5 quarters. The position peaked at $474K in Q4 2016. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Invictus RG reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Invictus RG sold 1,346 Hologic shares in Q3 2017, an estimated $61K.
  • Invictus RG first reported a position in Hologic in Q4 2015 and held it in 5 quarters.
  • Invictus RG's Hologic position peaked at $474K in Q4 2016.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Invictus RG's 13F filing for Q3 2017, filed 13 Nov 2017.